poor metabolizers of debrisoquin: Interactions of carvedilol with strong inhibitors of CYP2D6 (such as quinidine, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol .
<quinidine, effect, carvedilol>, <fluoxetine, effect, carvedilol>, <paroxetine, effect, carvedilol>, <propafenone, effect, carvedilol>